重编程工程化自体 T 细胞以克服 Merkel 细胞癌患者的耐药性
Reprogramming engineered autologous T cells to overcome resistance in patients with Merkel cell carcinoma.
CELL INTELLIGENCE · 肿瘤细胞治疗研究
肿瘤细胞治疗研究
英文原题:Predicting Tumor Antigens Using the LENS Workflow Through RAFT.
Predicting Tumor Antigens Using the LENS Workflow Through RAFT.
分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。
肿瘤细胞表面由MHC分子呈递的肿瘤特异性抗原和肿瘤相关抗原是个性化疫苗和T细胞受体工程T细胞(TCR-T)疗法的诱人靶点。准确预测合适的肿瘤抗原是一项相当大的挑战,需要在计算工具和实验方法上具备灵活性。在此,我们描述了用于可重复生物信息学的框架RAFT,以及我们高度模块化的新抗原预测工作流程LENS。我们提供了安装、运行和修改LENS以适应不同目的的分步说明。
Tumor-specific and tumor-associated antigens presented on the tumor cell surface by MHC molecules are enticing targets for personalized vaccination and T cell receptor-engineered T cell (TCR-T) therapy. Accurately predicting suitable tumor antigens is a considerable challenge and requires flexibility in both computational tools and experimental methods.
Here we describe our framework for reproducible bioinformatics, RAFT, as well as our highly modular neoantigen prediction workflow, LENS.
We provide step-by-step instructions for installation, running, and modifying LENS to suit different purposes.
MEMBER ACCOUNT
登录成功会直接打开下一页。